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Available online 11 August 2016Background: Weight loss may decrease risk of colorectal cancer in obese individuals, yet its effect in the
colorectum is not well understood. We used integrative network modeling, Passing Attributes between Net-
works for DataAssimilation, to estimate transcriptional regulatory networkmodels frommRNAexpression levels
from rectal mucosa biopsies measured pre- and post-weight loss in 10 obese, pre-menopausal women.
Results:We identiﬁed signiﬁcantly greater regulatory targeting of glucose transport pathways in the post-weight
loss regulatory network, including “regulation of glucose transport” (FDR = 0.02), “hexose transport” (FDR =
0.06), “glucose transport” (FDR = 0.06) and “monosaccharide transport” (FDR = 0.08). These ﬁndings were
not evident by gene expression analysis alone. Network analysis also suggested a regulatory switch from
NFΚB1 to MAX control of MYC post-weight loss.
Conclusions: These network-based results expand upon standard gene expression analysis by providing evidence
for a potential mechanistic alteration caused by weight loss.
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Diet1. Introduction
Obesity occurs in over one third of the American population and is
associated with increased risk of colorectal cancer [1,2]. However, it is
not clear if onemust be of normalweight throughout life to beprotected
against colorectal cancer or if weight loss decreases risk in obese indi-
viduals. It has been hypothesized that since weight loss decreases sys-
temic inﬂammation [3], weight loss may mediate anti-cancer effects in
the colorectum. Weight loss interventions have been successful
among individuals with high colorectal cancer risk [4]. However, there
is no deﬁned mechanism of action for this commonly prescribed cancer
prevention and lifestyle intervention.
Most human studies on the effect of body mass in colorectal cancer
have focused on the association between disease and weight gain, and
even those ﬁndings are inconsistent. For example, different studies
have found an increased risk for colorectal cancer in response to weight
gain (1) amongmen but not women [5], (2) only amongmen that were
overweight at baseline [6], or (3) among both men and women [7].
Most recently, Song et al. [8] observed a signiﬁcant 64% increased risk
for colorectal cancer among men who gained ≥20 kg in adulthood ver-
sus weight stable men, and a trend for a negative association betweentwork Medicine, Brigham and
ton, MA 02115, USA.
).
. This is an open access article underadult weight loss and colorectal cancer risk among men. Similar, but
weaker associations were also observed among women. Recent meta-
analyses on weight gain and colorectal cancer studies demonstrates an
increased risk of colon cancer among men, but not women, who gain
weight in adulthood [9–11].
Similarly, the few studies examining the effects of weight loss are
also inconsistent and often null. Although there are several reports of
an association of intentional weight loss with reduced colorectal cancer
[12] [13,14], many studies have been unable to ﬁnd this association [15]
[16] [17] [18]. These inconsistent results suggest the effects of weight
lossmay be BMI-, time-, dose- and even person-dependent and demon-
strates a need to better understand the impact of weight loss in the
colorectum of obese and overweight individuals. Further, these studies
do not allow for the disentanglement of effects due toweight loss versus
effects due to extreme changes in diet.
Obesity is a chronic inﬂammatory state, resulting in an increase in
circulating insulin, adipokines, and other hormones and leading to
changes in glucose transport and activation of the PI3K/mTOR pathway.
Subsequently, colorectal epithelial cells damaged by inﬂammation with
access to plenty of circulating glucose at their disposal are signaled to
grow and potentially undergo malignant transformation [19,20]. A pre-
vailing assumption is that the opposite mechanism is at work under
lower body fat, post-weight loss conditions. Indeed, those who lose
weight display more normal glucose regulation [21,22]. Circulating in-
sulin and hemoglobin A1C levels are also positively associated withthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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suggestive evidence that weight loss decreases circulating biomarkers
of inﬂammation [24], there is a lack of rigorous mechanistic and epide-
miological evidence linking intentional weight loss itself to decreased
colorectal cancer risk.
Modeling gene regulation as a complex network is an importantway
to characterize and explore the regulatorymechanismsmediating cellu-
lar processes [25]. Although there are many approaches for modeling
networks, it has become increasingly obvious that integrative ap-
proaches combining multiple sources of evidence produce the most in-
formative and accurate networks [26]. PANDA (Passing Attributes
between Networks for Data Assimilation; [27–30]) uses an integrative
message-passing approach to reconstruct gene regulatory networks.
What distinguishes PANDA from other approaches is its focus on infor-
mation ﬂow when estimating regulatory relationships. Speciﬁcally,
PANDA does not derive edges in the network from direct correlation
in expression patterns between a transcription factor and a downstream
target gene, but rather shared patterns of co-expression between com-
mon targets of a transcription factor.
In this studywe used PANDA to integrate publicly available gene ex-
pression data from rectal mucosal biopsy samples pre- and post-diet in-
duced weight loss in 10 women. With a prior regulatory map derived
from existing transcription factor binding motif information, we built
models representing the gene regulatory network of the colorectum
both pre- and post-weight loss ([31]; GSE20931). We then compared
these networks to characterize the effects of weight loss on cellular
pathways. Speciﬁcally, we identiﬁed a MYC- and glucose transport-re-
lated regulatory shift post-weight loss. Our results complement stan-
dard gene expression analyses by providing additional information
and allowing us to hypothesize on alterations in transcription factor
regulation-mediated expression changes. These changes can be used
to develop hypotheses on the biological processes of the colorectum
that are most affected in response to weight loss.Fig. 1. Schematic overview of the analyses performed. In a previous study [31] 10 obese, pre-men
(b800 kcals/day) to achieve N8% body weight loss and then provided an end-of-study rectal m
from the Gene Expression Omnibus database (GEO; GSE20931). Processing of this data inclu
highest index of dispersion across its expression values to represent that given gene's expre
COMBAT [49], and (3) averaging four duplicate baseline gene expression measurements to ob
Due to the small sample size, we randomly chose ﬁve participants from the ten total partic
individuals. We then applied Passing Attributes between Networks for Data Assimilation (PA
to estimate ﬁfty paired baseline and end-of-study gene regulatory networks. Both the proces
sets with either increased expression or targeting at end-of-study versus baseline. Finally, the
aggregate baseline network and one averaged, aggregate end-of-study network, respectfully.
network-based analysis including change in targeting (change out-degree) for transcription fa2. Results
2.1. Gene regulatory network models at baseline and end-of-study
We used PANDA to build network models of the gene regulatory
structure by combining transcription factor motif information with
gene expression data from paired mucosal biopsies collected from 10
pre-menopausal women both before (baseline) and after weight loss
(end-of-study; Fig. 1). Finding obese but otherwise healthy participants
who are able to adhere to a very low calories diet is challenging and
obtaining paired rectal biopsies from subjects is rare. While the number
of samples in this gene expression dataset is fairly small, we have previ-
ously used PANDA to model gene regulatory networks in other systems
with limited samples [22] and found that the algorithm is able to esti-
mate networkswhose structure provides insight into the underlying bi-
ology. It is this structure, and how it changes as a result of weight-loss,
that we investigate here.
To begin, we downloaded gene expression data from the Gene Ex-
pression Omnibus (GEO; GSE20931), corrected for batch effect, merged
replicate samples and selected the probe with the highest index of dis-
persion to represent each gene. PANDA was then used to integrate the
pairwise co-expression levels of genes (estimated using the Pearson
correlation) in either the baseline and end-of-study samples with a
prior regulatory network constructed by scanning promoter regions
(deﬁned as [+750, −250] around the TSS) for transcription factor
binding sites [32]. Because of the relatively small number of samples,
we used a jack-kniﬁng approach to build ﬁfty networks based on the
baseline samples and ﬁfty networks based on the end-of-study samples
[25]. We did this by creating 50 random subsamples of 5 participants
each. Each subsample contained an individual no more than one time
but individuals were represented in multiple subsamples. For each sub-
sample,we identiﬁed thepre- and post-weight loss expressiondata cor-
responding to the individuals in the subsample and applied PANDA toopausalwomenprovidedbaseline rectalmucosal biopsies, followed a very low calorie diet
ucosal biopsy sample. Gene expression data from these biopsy samples was downloaded
ded (1) collapsing probes representing the same gene by selecting the probe with the
ssion levels, (2) removing batch effects between the two expression chips by running
tain two expression samples for each participant, one at baseline and one at end of study.
ipants (without replacement). We did this multiple times to create ﬁfty subsamples of
NDA; [29]) to the gene expression data from individuals within each subsample in order
sed gene expression data and these 100 networks were input into GSEA to identify gene
baseline and end-of-study networks' edge values were averaged to create one averaged,
“High-conﬁdence” edges were identiﬁed within these aggregate networks and used for
ctors.
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We did this for all ﬁfty subsamples, resulting in ﬁfty baseline and ﬁfty
end-of-study networks. Becausewe selected samples from the same in-
dividuals when creating each baseline and end-of-study network, these
can be thought of as paired sets of networks, which can help us account
for between-subject heterogeneity in our analysis. For more informa-
tion on the expression and motif data processing and network model-
ing, please see Materials and methods.
We compared the ﬁfty baseline and ﬁfty end-of-study networks to
identify biological processes and pathways that are robustly differen-
tially-targeted between the pre- and post-weight loss states. To do
this, we ran Gene Set Enrichment Analysis (GSEA) [33,34] using the
in-degree of genes (number of transcription factors targeting that
gene) in our 50 baseline and 50 end-of-study networks as an input
[30]. Although no gene sets were signiﬁcantly enriched for increased
targeting at baseline compared to end-of-study, we observe a slight
trend for carbohydrate biosynthetic processes (Table 1; Table S1;
Table S2). On the other hand, four glucose transport pathways were
among the top signiﬁcantly enriched pathways at end-of-study (Table
1; Table S2): “regulation of glucose transport” (FDR = 0.02), “hexose
transport” (FDR= 0.06), “glucose transport” (FDR= 0.06) and “mono-
saccharide transport” (FDR= 0.08). This, juxtaposed with a suggestion
of biosynthesis at baseline (monosaccharide and hexose biosynthesis,
FDR q-value = 0.25 and 0.28, respectively), is evidence that there is a
shift away from carbohydrate synthesis and an increase in glucose
transport regulation in response to weight loss.
To evaluate whether these shifts in local network structure around
glucose transport genes would be evident from a standard gene expres-
sion-based analysis, gene expression values were input into GSEA from
our baseline and end-of-study samples. Consistent with our network-
based results, we did not ﬁnd any gene sets enriched at baseline (data
not shown). However, we found many processes related to mitochon-
drial function and cellular respiration signiﬁcantly enriched at end-of
study, as well as chemokine (FDR = 0.002) and cytokine activity
(FDR = 0.038) (Table S3). These latter two processes were alsoTable 1
Top 10 most signiﬁcant gene sets (pathways) with b75 members in baseline and end-of-
study based on a differential-targeting analysis using GSEA.
Enriched at Gene sets (pathways) ES NES FDR
Q-val
Baseline Oxidoreductase activity, acting on
NADH or NADPH, quinone or similar
compound as acceptor (MF)
0.484 1.716 0.209
Establishment of protein localization to
peroxisome (BP)
0.618 1.717 0.211
Peroxisome organization (BP) 0.563 1.767 0.212
Protein targeting to peroxisome (BP) 0.618 1.722 0.215
Nucleobase, nucleoside, nucleotide and
nucleic acid transmembrane
transporter activity (MF)
0.613 1.72 0.215
Regulation of lipid transport (BP) 0.495 1.749 0.215
Microvillus membrane (CC) 0.61 1.711 0.216
Response to fatty acid (BP) 0.575 1.745 0.217
L-amino acid transport (BP) 0.613 1.731 0.218
Tetrapyrrole metabolic process (BP) 0.515 1.757 0.218
End-of-study Receptor tyrosine kinase binding (MF) −0.635 −2.176 0.016
Translational initiation (BP) −0.565 −2.131 0.018
Regulation of glucose transport (BP) −0.505 −2.179 0.022
Hexose transport (BP) −0.445 −1.910 0.058
Glucose transport (BP) −0.445 −1.886 0.062
Monosaccharide transport (BP) −0.437 −1.854 0.079
Nuclear pore (CC) −0.430 −1.831 0.086
Transcription termination,
DNA-dependent (BP)
−0.418 −1.826 0.086
Somatic stem cell division (BP) −0.620 −1.838 0.088
Nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay (BP)
−0.510 −1.795 0.101
Abbreviatdions: enrichment score (ES), normalized ES (NES), False Discovery Rate (FDR),
biological process (BP), cellular component (CC), and molecular function (MF).identiﬁed by GSEA analysis of the gene expression data in the previous
analysis of this data, which used an older Gene Ontology dataset for
GSEA analyses [31]. It is interesting to note, however, that neither the
original analysis of the expression data, nor our re-analysis, identiﬁed
signiﬁcant differential-expression of the glucose transport genes.
2.2. Key transcription factors alter targeting from baseline to end-of-study
We next investigated which transcription factors might be driving
the changes in the networks between baseline and end-of-study. To
begin, we created a single aggregate baseline and a single aggregate
end-of-study network by averaging the 50 baseline and 50 end-of-
study networks, respectively. Next, we limited these aggregate net-
works to only include “high-conﬁdence” edges, which we identiﬁed
based on a combined probability score that represents both the likeli-
hood that a given edge exists and that is stronger in baseline compared
to end-of-study, or vice versus (see Materials and methods; Supple-
mentary data). To identify large-scale patterns thatmight deﬁne biolog-
ically meaningful differences between these two “high-conﬁdence”
subnetworks, we compared the change in out-degree (number of
gene targets) of each transcription factor [28]. Fig. 2A lists the twenty
transcription factors with the greatest absolute change in out-degree
(targeting) between the baseline and end-of-study high-conﬁdence
subnetworks and their corresponding “edge-enrichment score” [28].
For more information see Materials and methods.
The three transcription factors with the largest change in gene
targeting were MAX, which had 3588 more gene targets in the end-of-
study aggregate subnetwork compared to baseline, INSM1 which had
3201 fewer, and NFΚB1which had 2780 fewer (Fig. 2A). MYC (an onco-
genic factor and regulatory associate of these transcription factors; [35,
36,37,38]) also had a greatly increased level of gene targeting post
weight loss. However, the MYC::MAX heterodimer had overall de-
creased targeting (data not shown), suggesting that although both
MYC andMAX are both targetingmore genes post weight loss, this like-
ly is not the result of these two proteins working together in a protein
complex.
To gain a better understanding of the changes in the local regulatory
network around the top twenty transcription factors with altered regu-
latory partners, we visualized high-conﬁdence edges from the baseline
and end-of-study aggregate subnetworks that extend between any
pair of these top 20 transcription factors (Fig. 2B). It is important to
note that these subnetworks likely contain some false-positive edges;
however, it is also interesting that we observe a high-level of regulatory
activity around these transcription factors, with 75 high-conﬁdence
edges at baseline to 80 at end-of-study.
Wenext limited our view to the transcription factorswith the largest
changes in gene targeting in the aggregate subnetwork of high conﬁ-
dence edges (MAX, INSM1 andNFΚB1) and a shared transcription factor
target of key importance in carcinogenesis and cellular growth (MYC;
Fig. 2C) [39]. We observed a shift from reliance on NFΚB1 and INSM1
cross-talk to modulate MYC at baseline to MAX modulating both
INSM1 and MYC at end-of-study. This shift was observed despite the
fact that the average log-fold change values in expression for MAX,
INSM1 and NFKB1 were only 0.010,−0.026, and−0.001, respectively.
We also saw changes in co-expression levels among the targets of these
transcription factors, providing additional evidence of their importance
in mediating changes induced by weight loss, and helping to explain
this gene regulatory shift (Fig. S1).
2.3. AMYC-relatedmechanism for the shift towards glucose transport post-
weight loss
GSEA analysis of our network models indicated that genes involved
in glucose transport are differentially-targeted between baseline and
end-of-study (Table 1). Thus, we next examined the relationship be-
tween this ﬁnding and the network-rewiring we observed occurring
MAX
NFKB1
MYC
INSM1
PPARG::RXR A
ZFX
FOXL 1
PLAG1
HNF1B
FOXI 1
PAX5
POU5F1
INSM 1
MIZF
NOBOX
AR
NFKB1
MAX
MYC
MYCN
Baseline Edge
End-of-Study Edge
Highlighted TF
Out-degree 
at baseline
Out-degree at 
end-of-study
Abs. change 
in out-degree
EES of out-
degree
MAX 2385 5973 3588 1.355
INSM1 4585 1384 3201 -1.715
NFKB1 6201 3421 2780 -0.844
MIZF 3996 6723 2727 0.779
POU5F1 3909 1493 2416 -1.374
GATA2 3765 1507 2258 -1.306
PLAG1 5010 2790 2220 -0.829
MZF1_5-13 7733 5599 2134 -0.450
MYCN 1224 3217 1993 1.421
FOXI1 1759 3711 1952 1.104
HNF1B 3951 2057 1894 -0.925
MYC 1982 3861 1879 0.988
PPARG::RXRA 5114 3334 1780 -0.601
FOXL1 3862 2182 1680 -0.807
PAX5 7961 6386 1575 -0.301
ZFX 5252 6773 1521 0.393
NOBOX 3875 2357 1518 -0.700
NKX3-2 2008 3481 1473 0.819
AR 1056 2524 1468 1.282
SOX2 3257 1801 1456 -0.837
C. High-confidence edges between highlighted
Fig. 2. Changes in transcription factor targeting between high-conﬁdence baseline and end-of-study subnetworks. (A) The 20 transcription factors with the largest change in absolute
(abs.) out-degree between aggregate subnetworks of high conﬁdence edges from baseline to end-of-study. (B) Visualization of the high-conﬁdence edges that extend between any
pair of these transcription factors. Note that not every transcription factor motif had a corresponding gene name (e.g. PPARG::RXRA) and thus some nodes in this network only have
out-going edges (i.e. not all transcription factors are also gene targets). Three transcription factors (NFKB1, MAX and INSM1) with the largest change in targeting (e.g. out-degree) and
Myc (a key oncogenic factor and regulatory associate of these transcription factors) are highlighted in yellow. (C) The high conﬁdence edges between these four highlighted
transcription factors describe a shift in regulatory control from NFKB1 to MAX after weight loss. Of interest, these genes are mediators in glucose transport regulatory pathways.
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this we identiﬁed the subset of genes annotated to the regulation of glu-
cose transport, hexose transport, monosaccharide transport and/or glu-
cose transport gene sets used in the GSEA analysis. We then selected
high-conﬁdence edges that target at least one of these genes, resulting
in a subnetwork of 7949 high-conﬁdence glucose transport-speciﬁc
edges at baseline and a subnetwork of 8264 high-conﬁdence glucose
transport-speciﬁc edges at end-of-study.
As in the aggregate network of high-conﬁdence edges, we deter-
mined the number of genes targeted by each transcription factor in
these glucose transport-speciﬁc subnetworks. We observe that three
of our previously-identiﬁed transcription factors (NFKB1, MAX and
INSM1) have some of the largest changes in targeting between baseline
and end-of-study (Table 2). This conﬁrms the notion that the shift from
INSM1andNFΚB1 toMAX control (Fig. 2C) is a potentialmediator of the
shift in glucose transport regulation post-weight loss.
Our network analysis was able to discern changes in targeting
around glucose transport genes that were not identiﬁed in a differen-
tial-expression analysis. We therefore were also curious about the rela-
tionship between the re-wiring we observed around these glucose
pathway genes and their differential-expression between baseline and
end-of-study. To investigate this further, we directly compared the
log-fold change in expression from baseline to end-of-study with the
“edge enrichment score” (EES) for in- and out-degree for each gene
and transcription factor in the glucose transport-speciﬁc subnetwork
(Fig. 3; note that genes that are not also transcription factors will haveTable 2
Top 10 transcription factors with the largest change in out-degree of high conﬁdence
edges from baseline to end-of-study in the aggregate network restricted to only genes in-
volved in glucose transport pathways.
Transcription
factor
Baseline
out-degree
End-of-study
out-degree
Change in
out-degree
Absolute
change in
out-degree
Log2 (EES)
of
out-degree
NFKB1 108 42 −66 66 −1.419
MAX 33 90 57 57 1.391
MZF1_5-13 130 80 −50 50 −0.757
INSM1 67 19 −48 48 −1.874
MIZF 67 107 40 40 0.619
NFIL3 29 69 40 40 1.194
E2F1 40 79 39 39 0.926
FOXD3 23 61 38 38 1.351
SOX17 36 74 38 38 0.983
PAX5 127 90 −37 −37 −0.553
Glucose transport pathway genes includes genes annotated to at least one of four Gene
Ontology categories: “glucose transport”, “hexose transport”, “monosaccharide transport”
and “regulation of glucose transport”. Abbreviations: Edge Enrichment Score (EES).a nominal out-degree EES of zero). Expression (log-fold change), EES
in-degree and EES out-degree all provide different information about
genes in the glucose regulatory pathway, emphasizing the importance
of investigating the information highlighted in each of the three data
analyses.
3. Discussion
Network-based gene expression analysis of rectal mucosa biopsy
samples from10obese, pre-menopausalwomenbefore and after super-
vised, diet-inducedweight loss suggests thatweight loss leads to chang-
es in glucose/carbohydrate transport via a shift from INSM1 and NFΚB1,
to MAX gene regulatory control. These results complement earlier ob-
servations of a decrease in NFΚB1-related inﬂammation, and a decrease
in fasting glucose (meanbaseline = 95 mg/dL, meanend-of-study = 85 mg/
dL), and triglycerides (meanbaseline = 122 mg/dL, meanend-of-study =
93mg/dL) in thesewomen [31]. Additionally, our ﬁndings also describe
aMAX-basedmechanism for the observed increase in glucosemobiliza-
tion and/or use along with less biosynthesis.
Obesity-associated colorectal cancer has been hypothesized to be
mediated by exposure of the colorectum to chronic inﬂammatory in-
sults in the presence of abundant glucose [21–24,40] but the mecha-
nisms of weight loss on the colorectum that mediate colorectal cancer
risk are not well understood. A standard GSEA analysis of gene expres-
sion levels in these participants, alongwithmeasuring biomarkers of in-
ﬂammation, previously provided evidence that weight loss induces a
decrease in inﬂammatory related genes (JUN and FOS), inﬂammatory
pathways (cytokine activity, chemokine receptor binding, chemokine
activity, etc.) and led to the hypothesis that these changes were modu-
lated by TNF-α, IL-6, IL-1, and IL-8 [31].
The PANDA-based network approach we describe herein not only
identiﬁed many of these same changes in inﬂammatory pathways, but
also highlighted an important shift in the targeting of glucose regulatory
pathways. Additionally, this network-based analysis allowed us to iden-
tify a possiblemechanismbywhichweight loss decreases inﬂammation
and alters glucose transport in rectal mucosa. Although little change in
mRNA expression levels of NFΚB1, INSM1 and MAX was observed, our
integrative network models depict a striking decrease in the number
of genes targeted by NFΚB1 and INSM1 post-weight loss, whileMAX in-
creased the number of genes it targeted. To our knowledge this is the
ﬁrst description of a shift in gene regulatory control post-weight loss
to MAX.
INSM1, NFΚB1 andMAX are all involved in glucosemetabolism and/
or inﬂammation. Perhaps the best studied of the three is NFΚB1, which
is activated by pro-inﬂammatory pathways observed in obese persons,
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130 A.J. Vargas et al. / Genomics 108 (2016) 126–133confers a selective growth advantage [41] and promotes epithelial to
mesenchymal transition of colorectal cells [42]. It is also thought to con-
tribute to the risk of colorectal cancer [43].While targets of INSM1 in the
rectum are unknown, INSM1 has been shown to target the AKT/PI3K
pathway in the pancreas [44] which itself regulates glucose transport
via mTOR [45]. MAX's involvement in glucose regulation is likely medi-
ated through its MYC-related mechanisms described below [37,38].
The oncogenic, growth promoting transcription factor MYC is medi-
ated by all three genes of interest. Speciﬁcally, NFΚB1 promotesMYCex-
pression [36], while INSM1 is a target of MYC [35], and MAX
heterodimerizes with MYC to form MYC::MAX [37,38]. However, as
we observed a large increase in MAX targeting genes from baseline to
end-of-study, we simultaneously observed a large decrease in
MAX::MYC targeting. Thus instead of dimerizingwithMYC afterweight
loss, MAX likely forms aMAX::MAX homodimer which has been shown
in vitro to repress MYC-induced cell growth andmalignant transforma-
tion [37,38].
In addition to being a proliﬁc regulator of cell growth and oncogen-
esis, MYC also regulates a majority of the genes that regulate glycolysis
[46]. However, in part due to the key roleMYC plays in normal cell func-
tions, designing drugs to target MYC has been incredibly challenging
[39]. We suggest that it may be reasonable to combine already available
NFKB inhibiting drugs [47], and/or to develop agents that inhibit INSM1
or promote MAX in order to induce the anti-inﬂammatory and glucose
regulatory changes that weight loss induces for cancer prevention or,
potentially, weight loss induction itself.
Integrative network modeling has previously been used to describe
the tissue-speciﬁc effects ofweight loss in adipose tissue [48]. Our appli-
cation of PANDA similarly demonstrates how network approaches help
to build upon previous gene expression-based ﬁndings [31]. However,
we recognize that our results are limited by the inability to assign
cause to weight loss versus extreme dietary change since they occurred
concurrently in these participants, a lack of protein measurements,
biases in the available transcription factormotif datasets, and the poten-
tial for false positives due to the small number of gene expression sam-
ples used to construct the networks. One reason we chose to model
networks using this particular dataset was that is contained paired sam-
ples from the same individual, minimizing the effects of the underlying
heterogeneity across individuals in our analysis and allowing us to focus
on changes that are most likely a result of weight loss. By subsampling,
we alsominimized the effect of changes in gene expression that are spe-
ciﬁc to only one individual (outliers). In addition, to mitigate the inﬂu-
ence of false-positive edges in our networks, we chose to focus on
large-scale changes, such as alterations in transcription factor degree,
or in the targeting patterns around a set of pathway genes. Despite tak-
ing these precautions,we recognize that future studieswill be needed to
conﬁrm our proposed NFΚB1/INSM1 to MAX regulatory shift mecha-
nism in model systems by measuring protein levels.
In summary, using network modeling, we identiﬁed a signiﬁcant
change in targeting of glucose transport genes in the rectal mucosa of
overweight women who underwent intentional weight loss. These
changes were explained by a putative mechanism whereby NFΚB1Fig. 3. Comparison of changes in expression and targeting for genes in glucose transport
regulatory pathways. The three columns of the heatmap show the (1) log2-fold change
gene expression levels between baseline and end-of-study (“Expression”), (2) the Edge
Enrichment Scores (EES) calculated based on change in gene in-degree between the
aggregate subnetworks when restricted to genes involved in glucose transport (see
Table 2), and (3) the EES calculated based on change in gene out-degree between the
aggregate subnetworks when restricted to genes involved in glucose transport (see
Table 2). Clear differences between the expression data and the EES are likely a result of
PANDA's focus on integrating gene co-expression information with a regulatory motif
prior (see Fig. S1). A value of zero indicates no change in expression, EES in-degree or
EES out-degree for a given gene from baseline to end-of-study. *There are many fewer
changes observed for EES out-degree as compared to in-degree because many genes are
targets and thus have in-degrees, but many fewer genes also serve as transcription
factors. Thus there are many genes with zero out-degree at both baseline and end-of-
study.
131A.J. Vargas et al. / Genomics 108 (2016) 126–133and INSM1 decrease their gene targeting activity andMAX takes over to
alter MYC and other glucose and inﬂammatory gene expression levels.
Although these ﬁndings are highly promising, we recognize that this
mechanism needs to be conﬁrmed in model systems before moving to-
wards targeting of these transcription factors as potential inducers of
weight loss and/or cancer preventative therapies.
4. Materials and methods
4.1. Participants and data source
In a previous study [31] ten obese, pre-menopausal women (mean
age = 43; Fig. 1) were enrolled in a weight loss trial. Brieﬂy, exclusion
criteria for participation included not being weight stable (≥6 months),
history of cancer, current weight loss treatment, history of intestinal
surgery, history “suggestive of malabsorption”, other major medical
concerns, use of anti-inﬂammatory medications or medications with
contraindications for severe weight loss/low calorie diet. Participants
were put on a closely supervised, low calorie diet (b800 kcals/day)
until they lost N8% of body weight. Mean body weight loss was 10.1%
andmean time on study was 46.5 days. Gene expression wasmeasured
onmucosal biopsies taken at baseline and end-of-study. These gene ex-
pression data were then deposited in the Gene Expression Omnibus
(GEO;GSE20931) as anonymous data after all identiﬁerswere removed.
Additional participant characteristics and weight-related biomarker
changes related to this dataset can be found in [31]. This weight loss
study was originally approved by the Institutional Review Board of
The Rockefeller University (New York, NY), where written informed
consent was obtained prior to study participation.
4.2. Expression data processing
Wedownloaded *.soft ﬁles containing normalizedmRNA expression
levels from the mucosal biopsies (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE20931). This data included a total of 24 anony-
mous gene expression samples, with 10 baseline and 10 end-of-study
samples (one baseline and one end-of-study for each participant),
plus replicates for four of the baseline samples. A *.geo and *.annot ﬁle
containing the keys to convert Illumina probe IDs to gene symbols for
each gene were also downloaded from GEO and used to annotate the
gene expression ﬁles.
We corrected for batch effects using COMBAT (R package, [49]) in R
(RStudio version 0.98.994, RStudio Inc., Boston, MA; Fig. 1). For genes
with multiple probes, the probe with the highest index of dispersion,
deﬁned as the variance divided by the mean, was chosen to represent
the expression levels for that gene. Finally, replicate gene expression
values (for the four participantswith duplicate gene expression samples
at baseline)were averaged. This resulted in 10 baseline expression sam-
ples and 10 end-of-study expression samples that were used for subse-
quent analyses.
4.3. Analysis using gene expression data
We downloaded human Gene Ontology annotation information
from www.geneontology.org and built a *.gmt ﬁle containing sets of
genes annotated to 15,033 different Gene Ontology (GO) categories.
To evaluate the differential-expression of these gene sets between base-
line and end-of-study, we ran Gene Set Enrichment Analysis (GSEA;
Broad Institute, Cambridge, MA; http://www.broadinstitute.org/gsea/
index.jsp; [33,34]), comparing the expression levels in the 10 baseline
and 10 end-of-study expression samples.
4.4. Network model development
Networks were derived using Passing Attributes between Networks
for Data Assimilation (PANDA; [29]; Fig. 1). PANDA combines co-expression of genes based on Pearson correlations and a prior regulato-
ry network. Tominimize the effect of outliers in our networks built on a
smaller sample size (n= 10), ﬁve participants were chosen at random
(without replacement) to form subsamples. 50 subsamples were
formed such that no participants were in the same subsample twice
but participants could be inmultiple different subsamples. Gene expres-
sion from these subsamples of participants was used to reconstruct 50
baseline gene regulatory networks and 50 end-of-study gene regulatory
networks. Namely, gene expression data for each group of ﬁve partici-
pants was integrated with a prior network structure using PANDA
with the alpha parameter set at 0.25 (indicating a high degree of mes-
sage passing).
The prior regulatory network was estimated by scanning the human
genome for 130 position weightmatrixes (PWM) from the JASPAR core
vertebrate transcription factor database [32]. To determine locations for
each motif, each sequence S was given a score equal to log [P(S|M)/
P(S|B)], where P(S|M) is the probability of observing sequence S
given motif M and P(S|B) is the probability of observing sequence S
given the genome background B. The background distribution of motif
scores was determined by randomly sampling the genome 106 times.
Motif sites that fell within the promoter region ([−750,+250] base-
pairs around the transcriptional start site) of one of the genesmeasured
in the expression data with a signiﬁcance b10−5 were used to deﬁne
edges between a transcription factor and gene in the regulatory net-
work prior.
In total 50 baseline and 50 end-of-study (100 total) directed, fully
connected networks were derived. The nodes in these networks are
genes (either transcription factors, gene targets or both) and the
edges each have an associated Z-score weight indicating the probability
that the edge exists. 17,511 genes were included in the expression data
and were targeted by at least one TF motif in our regulatory prior,
resulting in weight values for 2,276,429 edges in each network. Note
that not all transcription factors from the regulatory motif prior were
measured on the expression chip.
4.5. Network analysis
4.5.1. Gene set targeting analysis
We evaluated differential-targeting of gene sets (pathways) as in
[30]. Namely, for each of the 100 reconstructed networks, we calculated
the weighted in-degree of each target gene by summing the Z-score
weights for all edges to that gene. Then, to identify gene sets that are dif-
ferentially-targeted between baseline and end-of-study, we ran GSEA
comparing the weighted in-degree values across the 50 baseline and
50 end-of-study networks.
4.5.2. Deﬁning subnetworks and evaluating TF/gene edge enrichment
We also generated a single, aggregate baseline and single, aggregate
end-of-study network by averaging edgeweights across the 50 baseline
networks and 50 end-of-study networks, respectively (Supplementary
data). We evaluated these aggregate networks as in [28] and deﬁned
an edge conﬁdence score (EC) for each network:
Baseline : ECbij ¼ CDF−1 Zbij
 
CDF−1 Zbij−Z
e
ij
 
End‐of‐study : ECeij ¼ CDF−1 Zeij
 
CDF−1 Zeij−Z
b
ij
 
where Zijb is the z-score weight of the edge between node i and j in the
baseline network, Zije is the z-score edge-weight in the end-of-study net-
work and CDF−1 is the inverse cumulative distribution function of a
normal distribution. We then identiﬁed “high-conﬁdence edges” as
those with EC N 0.25 (~24% of all edges met this criterion). High-conﬁ-
dence edges at baseline (ECb N 0.25) can be interpreted as edges that
are both likely to exist in the baseline network and that have increased
evidence in the baseline as opposed to the end-of-study network; the
132 A.J. Vargas et al. / Genomics 108 (2016) 126–133inverse is true of high-conﬁdence edges at end-of-study. These edges
deﬁne distinct subnetworks for baseline and end-of-study. When the
aggregate networks were restricted only to edges of high-conﬁdence,
the baseline network had 548,736 edges, while the end-of-study net-
work had 540,701 edges.
We quantiﬁed differences in gene targeting between these high-
conﬁdence-edge subnetworks by calculating the change in degree (ei-
ther in-degree or out-degree) for each gene (i) and using an Edge En-
richment Score (EES [23]):
EESi ¼ log2
kei =k
b
i
Ne=Nb:
where kie and kib are the degree of high-conﬁdence edges for gene i in the
end-of-study and baseline subnetworks, respectively, and Ne andNb are
the total number of edges that make up the end-of-study and baseline
subnetworks. Note that the EES will be positive for edge-enrichment
around a particular gene in the end-of-study subnetwork, and negative
for edge-enrichment around a gene in the baseline subnetwork.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ygeno.2016.08.001.
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